WASHINGTON (Reuters) – U.S. regulators on Thursday approved a new children's vaccine from GlaxoSmithKline PLC that targets two common causes of bacterial meningitis, which can be fatal
U.S. approves Glaxo meningitis vaccine for children
June 14, 2012 By
